Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer
Background Persistent controversy exists with regard to how and when patients with head and neck cancer should undergo imaging after definitive therapy. The current study was conducted to evaluate whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for...
Gespeichert in:
| Veröffentlicht in: | Cancer 2021-02, Vol.127 (4), p.535-543 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 543 |
|---|---|
| container_issue | 4 |
| container_start_page | 535 |
| container_title | Cancer |
| container_volume | 127 |
| creator | Morgan, Rustain L. Eguchi, Megan M. McDermott, Jessica Mueller, Adam C. Amini, Arya Goddard, Julie A. Trivedi, Premal S. Karam, Sana D. |
| description | Background
Persistent controversy exists with regard to how and when patients with head and neck cancer should undergo imaging after definitive therapy. The current study was conducted to evaluate whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma.
Methods
A retrospective study of National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program–Medicare‐linked data in patients with an advanced stage of the 3 most common head and neck malignancies (oral cavity, oropharynx, and larynx) was conducted. Hazard ratios and 95% CIs for cancer‐specific survival were estimated for patients diagnosed with any of these cancers between 2006 and 2015.
Results
Significant improvement with regard to cancer‐specific survival was observed among patients with American Joint Committee on Cancer stage III and stage IVA laryngeal cancer who underwent positron emission tomography (PET) and/or computed tomography (CT) imaging during the first 6 months after receipt of definitive treatment (hazard ratio, 0.517; 95% CI, 0.33‐0.811) compared with those who underwent CT. There was a trend toward an improvement in cancer‐specific survival among patients with oral cavity or oropharyngeal malignancies who underwent PET/CT imaging, but it did not reach statistical significance.
Conclusions
Compared with CT imaging, posttreatment imaging with PET was associated with improved survival in patients with advanced laryngeal carcinoma.
Persistent controversy exists regarding how and when patients with head and neck cancer should undergo imaging after receiving definitive therapy. The current study evaluates whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma and finds that, compared with computed tomography imaging, posttreatment imaging using positron emission tomography is associated with improved survival in patients with advanced laryngeal carcinoma. |
| doi_str_mv | 10.1002/cncr.33244 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2482623930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2482623930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3934-847d0c1f4a40235b0c4da391a2b0de3470a42f46437addfabfaae0357ccb21323</originalsourceid><addsrcrecordid>eNp9kMtKw0AUhgdRbK1ufAAZcCekzi1Ns5TgDaqCKLgLJzNn2tTm4kza0rd3aqtLV-fCx3c4PyHnnA05Y-Ja19oNpRRKHZA-Z2kSMa7EIekzxsZRrORHj5x4Pw9jImJ5THpScp7yZNQnq6ypWnDQlSukaC3qbVej97SxtG181zmErsK6o2UF07Ke0qoxsCi7Ej21jaNPaEoNDmkbLIHzdF12MwpmBbVGQ2cIhkJtaI36k-rt0p2SIwsLj2f7OiDvd7dv2UM0ebl_zG4mkZapVNFYJYZpbhUoJmRcMK0MyJSDKJhBqRIGSlg1UjIBYywUFgCZjBOtC8GlkANyufO2rvlaou_yebN0dTiZCzUWIxHOsEBd7SjtGu8d2rx14Vm3yTnLtxHn24jzn4gDfLFXLosKzR_6m2kA-A5Ylwvc_KPKs-fsdSf9Bq-DiH4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2482623930</pqid></control><display><type>article</type><title>Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer</title><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><source>Alma/SFX Local Collection</source><creator>Morgan, Rustain L. ; Eguchi, Megan M. ; McDermott, Jessica ; Mueller, Adam C. ; Amini, Arya ; Goddard, Julie A. ; Trivedi, Premal S. ; Karam, Sana D.</creator><creatorcontrib>Morgan, Rustain L. ; Eguchi, Megan M. ; McDermott, Jessica ; Mueller, Adam C. ; Amini, Arya ; Goddard, Julie A. ; Trivedi, Premal S. ; Karam, Sana D.</creatorcontrib><description>Background
Persistent controversy exists with regard to how and when patients with head and neck cancer should undergo imaging after definitive therapy. The current study was conducted to evaluate whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma.
Methods
A retrospective study of National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program–Medicare‐linked data in patients with an advanced stage of the 3 most common head and neck malignancies (oral cavity, oropharynx, and larynx) was conducted. Hazard ratios and 95% CIs for cancer‐specific survival were estimated for patients diagnosed with any of these cancers between 2006 and 2015.
Results
Significant improvement with regard to cancer‐specific survival was observed among patients with American Joint Committee on Cancer stage III and stage IVA laryngeal cancer who underwent positron emission tomography (PET) and/or computed tomography (CT) imaging during the first 6 months after receipt of definitive treatment (hazard ratio, 0.517; 95% CI, 0.33‐0.811) compared with those who underwent CT. There was a trend toward an improvement in cancer‐specific survival among patients with oral cavity or oropharyngeal malignancies who underwent PET/CT imaging, but it did not reach statistical significance.
Conclusions
Compared with CT imaging, posttreatment imaging with PET was associated with improved survival in patients with advanced laryngeal carcinoma.
Persistent controversy exists regarding how and when patients with head and neck cancer should undergo imaging after receiving definitive therapy. The current study evaluates whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma and finds that, compared with computed tomography imaging, posttreatment imaging using positron emission tomography is associated with improved survival in patients with advanced laryngeal carcinoma.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.33244</identifier><identifier>PMID: 33119176</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cancer ; Computed tomography ; computed tomography (CT) ; Epidemiology ; Government programs ; Head & neck cancer ; head and neck cancer ; imaging ; Laryngeal cancer ; Laryngeal carcinoma ; Larynx ; Medical imaging ; Medicare ; Oncology ; Oral cavity ; Oropharynx ; Positron emission ; Positron emission tomography ; positron emission tomography/computed tomography (PET/CT) ; Squamous cell carcinoma ; surveillance ; Survival ; Tomography</subject><ispartof>Cancer, 2021-02, Vol.127 (4), p.535-543</ispartof><rights>2020 American Cancer Society</rights><rights>2020 American Cancer Society.</rights><rights>2021 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3934-847d0c1f4a40235b0c4da391a2b0de3470a42f46437addfabfaae0357ccb21323</citedby><cites>FETCH-LOGICAL-c3934-847d0c1f4a40235b0c4da391a2b0de3470a42f46437addfabfaae0357ccb21323</cites><orcidid>0000-0002-8311-9159 ; 0000-0002-3881-7257</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.33244$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.33244$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27923,27924,45573,45574,46408,46832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33119176$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morgan, Rustain L.</creatorcontrib><creatorcontrib>Eguchi, Megan M.</creatorcontrib><creatorcontrib>McDermott, Jessica</creatorcontrib><creatorcontrib>Mueller, Adam C.</creatorcontrib><creatorcontrib>Amini, Arya</creatorcontrib><creatorcontrib>Goddard, Julie A.</creatorcontrib><creatorcontrib>Trivedi, Premal S.</creatorcontrib><creatorcontrib>Karam, Sana D.</creatorcontrib><title>Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Background
Persistent controversy exists with regard to how and when patients with head and neck cancer should undergo imaging after definitive therapy. The current study was conducted to evaluate whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma.
Methods
A retrospective study of National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program–Medicare‐linked data in patients with an advanced stage of the 3 most common head and neck malignancies (oral cavity, oropharynx, and larynx) was conducted. Hazard ratios and 95% CIs for cancer‐specific survival were estimated for patients diagnosed with any of these cancers between 2006 and 2015.
Results
Significant improvement with regard to cancer‐specific survival was observed among patients with American Joint Committee on Cancer stage III and stage IVA laryngeal cancer who underwent positron emission tomography (PET) and/or computed tomography (CT) imaging during the first 6 months after receipt of definitive treatment (hazard ratio, 0.517; 95% CI, 0.33‐0.811) compared with those who underwent CT. There was a trend toward an improvement in cancer‐specific survival among patients with oral cavity or oropharyngeal malignancies who underwent PET/CT imaging, but it did not reach statistical significance.
Conclusions
Compared with CT imaging, posttreatment imaging with PET was associated with improved survival in patients with advanced laryngeal carcinoma.
Persistent controversy exists regarding how and when patients with head and neck cancer should undergo imaging after receiving definitive therapy. The current study evaluates whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma and finds that, compared with computed tomography imaging, posttreatment imaging using positron emission tomography is associated with improved survival in patients with advanced laryngeal carcinoma.</description><subject>Cancer</subject><subject>Computed tomography</subject><subject>computed tomography (CT)</subject><subject>Epidemiology</subject><subject>Government programs</subject><subject>Head & neck cancer</subject><subject>head and neck cancer</subject><subject>imaging</subject><subject>Laryngeal cancer</subject><subject>Laryngeal carcinoma</subject><subject>Larynx</subject><subject>Medical imaging</subject><subject>Medicare</subject><subject>Oncology</subject><subject>Oral cavity</subject><subject>Oropharynx</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>positron emission tomography/computed tomography (PET/CT)</subject><subject>Squamous cell carcinoma</subject><subject>surveillance</subject><subject>Survival</subject><subject>Tomography</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKw0AUhgdRbK1ufAAZcCekzi1Ns5TgDaqCKLgLJzNn2tTm4kza0rd3aqtLV-fCx3c4PyHnnA05Y-Ja19oNpRRKHZA-Z2kSMa7EIekzxsZRrORHj5x4Pw9jImJ5THpScp7yZNQnq6ypWnDQlSukaC3qbVej97SxtG181zmErsK6o2UF07Ke0qoxsCi7Ej21jaNPaEoNDmkbLIHzdF12MwpmBbVGQ2cIhkJtaI36k-rt0p2SIwsLj2f7OiDvd7dv2UM0ebl_zG4mkZapVNFYJYZpbhUoJmRcMK0MyJSDKJhBqRIGSlg1UjIBYywUFgCZjBOtC8GlkANyufO2rvlaou_yebN0dTiZCzUWIxHOsEBd7SjtGu8d2rx14Vm3yTnLtxHn24jzn4gDfLFXLosKzR_6m2kA-A5Ylwvc_KPKs-fsdSf9Bq-DiH4</recordid><startdate>20210215</startdate><enddate>20210215</enddate><creator>Morgan, Rustain L.</creator><creator>Eguchi, Megan M.</creator><creator>McDermott, Jessica</creator><creator>Mueller, Adam C.</creator><creator>Amini, Arya</creator><creator>Goddard, Julie A.</creator><creator>Trivedi, Premal S.</creator><creator>Karam, Sana D.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><orcidid>https://orcid.org/0000-0002-8311-9159</orcidid><orcidid>https://orcid.org/0000-0002-3881-7257</orcidid></search><sort><creationdate>20210215</creationdate><title>Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer</title><author>Morgan, Rustain L. ; Eguchi, Megan M. ; McDermott, Jessica ; Mueller, Adam C. ; Amini, Arya ; Goddard, Julie A. ; Trivedi, Premal S. ; Karam, Sana D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3934-847d0c1f4a40235b0c4da391a2b0de3470a42f46437addfabfaae0357ccb21323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer</topic><topic>Computed tomography</topic><topic>computed tomography (CT)</topic><topic>Epidemiology</topic><topic>Government programs</topic><topic>Head & neck cancer</topic><topic>head and neck cancer</topic><topic>imaging</topic><topic>Laryngeal cancer</topic><topic>Laryngeal carcinoma</topic><topic>Larynx</topic><topic>Medical imaging</topic><topic>Medicare</topic><topic>Oncology</topic><topic>Oral cavity</topic><topic>Oropharynx</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>positron emission tomography/computed tomography (PET/CT)</topic><topic>Squamous cell carcinoma</topic><topic>surveillance</topic><topic>Survival</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morgan, Rustain L.</creatorcontrib><creatorcontrib>Eguchi, Megan M.</creatorcontrib><creatorcontrib>McDermott, Jessica</creatorcontrib><creatorcontrib>Mueller, Adam C.</creatorcontrib><creatorcontrib>Amini, Arya</creatorcontrib><creatorcontrib>Goddard, Julie A.</creatorcontrib><creatorcontrib>Trivedi, Premal S.</creatorcontrib><creatorcontrib>Karam, Sana D.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morgan, Rustain L.</au><au>Eguchi, Megan M.</au><au>McDermott, Jessica</au><au>Mueller, Adam C.</au><au>Amini, Arya</au><au>Goddard, Julie A.</au><au>Trivedi, Premal S.</au><au>Karam, Sana D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2021-02-15</date><risdate>2021</risdate><volume>127</volume><issue>4</issue><spage>535</spage><epage>543</epage><pages>535-543</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Background
Persistent controversy exists with regard to how and when patients with head and neck cancer should undergo imaging after definitive therapy. The current study was conducted to evaluate whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma.
Methods
A retrospective study of National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program–Medicare‐linked data in patients with an advanced stage of the 3 most common head and neck malignancies (oral cavity, oropharynx, and larynx) was conducted. Hazard ratios and 95% CIs for cancer‐specific survival were estimated for patients diagnosed with any of these cancers between 2006 and 2015.
Results
Significant improvement with regard to cancer‐specific survival was observed among patients with American Joint Committee on Cancer stage III and stage IVA laryngeal cancer who underwent positron emission tomography (PET) and/or computed tomography (CT) imaging during the first 6 months after receipt of definitive treatment (hazard ratio, 0.517; 95% CI, 0.33‐0.811) compared with those who underwent CT. There was a trend toward an improvement in cancer‐specific survival among patients with oral cavity or oropharyngeal malignancies who underwent PET/CT imaging, but it did not reach statistical significance.
Conclusions
Compared with CT imaging, posttreatment imaging with PET was associated with improved survival in patients with advanced laryngeal carcinoma.
Persistent controversy exists regarding how and when patients with head and neck cancer should undergo imaging after receiving definitive therapy. The current study evaluates whether the type of imaging modality used in posttreatment imaging impacts cancer‐specific survival for patients with advanced head and neck squamous cell carcinoma and finds that, compared with computed tomography imaging, posttreatment imaging using positron emission tomography is associated with improved survival in patients with advanced laryngeal carcinoma.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33119176</pmid><doi>10.1002/cncr.33244</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8311-9159</orcidid><orcidid>https://orcid.org/0000-0002-3881-7257</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2021-02, Vol.127 (4), p.535-543 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_journals_2482623930 |
| source | Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals; Alma/SFX Local Collection |
| subjects | Cancer Computed tomography computed tomography (CT) Epidemiology Government programs Head & neck cancer head and neck cancer imaging Laryngeal cancer Laryngeal carcinoma Larynx Medical imaging Medicare Oncology Oral cavity Oropharynx Positron emission Positron emission tomography positron emission tomography/computed tomography (PET/CT) Squamous cell carcinoma surveillance Survival Tomography |
| title | Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A18%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20effectiveness%20of%20posttreatment%20imaging%20modalities%20for%20Medicare%20patients%20with%20advanced%20head%20and%20neck%20cancer&rft.jtitle=Cancer&rft.au=Morgan,%20Rustain%20L.&rft.date=2021-02-15&rft.volume=127&rft.issue=4&rft.spage=535&rft.epage=543&rft.pages=535-543&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.33244&rft_dat=%3Cproquest_cross%3E2482623930%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2482623930&rft_id=info:pmid/33119176&rfr_iscdi=true |